July 5 (Reuters) - European Medicines Agency:
* EMA: EMA'S CHMP APPROVED A NEW MANUFACTURING SITE FOR THE ACTIVE SUBSTANCE OF COVID-19 VACCINE NUVAXOVID: 05/07/2022 Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.93 USD | +4.67% | +20.54% | +2.71% |
04-15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
04-15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |
July 5 (Reuters) - European Medicines Agency:
* EMA: EMA'S CHMP APPROVED A NEW MANUFACTURING SITE FOR THE ACTIVE SUBSTANCE OF COVID-19 VACCINE NUVAXOVID: 05/07/2022 Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+2.71% | 687M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |